What is tricuspid regurgitation (TR)?
Tricuspid regurgitation (TR) is a serious cardiac condition that occurs when the tricuspid valve, which regulates blood flow between the right atrium and the right ventricle, fails to close properly, causing blood to flow back into the right atrium.
TR in the wider heart valve disease landscape
Heart valve diseases affect tens of millions of patients worldwide. TR impacts over 1.6 million patients in the US and over 3 million in Europe.
Over the past decade, innovative minimally invasive catheter-based solutions have been developed for the treatment of aortic and mitral valve disease. However, until recently, effective minimally invasive options for TR have been limited.
Strong clinical need for
transcatheter solutions for TR
High market potential that is
continuously growing
Strong and highly motivated team
Strong IP protection
Unique design for safe, easy and
quick treatment
Pioneering tricuspid valve replacement
TRiCares is a global business, with offices in France, Germany, the US and Brazil. Our vision is to bring to market a catheter-based tricuspid valve replacement system that will help patients suffering from severe tricuspid regurgitation (TR) without the need for open-heart surgery.
